J2786 HCPCS Level II code: Injection, reslizumab, 1 mg
J2786 is the HCPCS code for “Injection, reslizumab, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2786Injection, reslizumab, 1 mg
Short description: Injection, reslizumab, 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2786 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J2786 sits
- 1J codesDrugs administered other than orally
- 2Active code J2786Injection, reslizumab, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2786 mean?
J2786 is the HCPCS code for “Injection, reslizumab, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2786?
CMS lists J2786’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2786
All J codesJ2779Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mgJ2780Injection, ranitidine hydrochloride, 25 mgJ2781Injection, pegcetacoplan, intravitreal, 1 mgJ2782Injection, avacincaptad pegol, 0.1 mgJ2783Injection, rasburicase, 0.5 mgJ2785Injection, regadenoson, 0.1 mgJ2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 mlJ2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 mlJ2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iuJ2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu